Bulletin of Semashko National Research Institute of Public HealthBulletin of Semashko National Research Institute of Public Health2415-84102415-8429FSSBI «N.A. Semashko National Research Institute of Public Health»300010.25742/NRIPH.2023.02.009Научная статьяOn the issue of the prevalence of rosacea in various populations, taking into account risk factors, genetic predisposition and the peculiarities of the organization of medical careСадыковаРомина Н.sadykovaromina23@gmail.comПлутницкийАндрей Н.mbufmbc@mail.ruМингазовРустем Н.mrn85@mail.ruБеспятыхЮлия А.JuliaBes@rcpcm.orgBiomedical University of Innovation and Continuing Education of the State Scientific Center of the Russian Federation — A. I. Burnazyan Federal Medical Biophysical Center of the Federal Medical Biological Agency of Russia, Moscow, Russian FederationN. A. Semashko National Research Institute of Public Health, 105064, Moscow, Russian FederationResearch Institute for Healthcare and Medical Management of Moscow Healthcare Department, Moscow, Russian FederationLopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency151220232616816102025Copyright © 2023,2023The article provides an analysis of modern scientific literature on the prevalence at the population level of one of the main types of chronic inflammatory skin disease — rosacea, and also discusses the risk factors for the development of this disease. It has been shown that in most countries of the world, rosacea is diagnosed on average in 5.5% of the able-bodied active population, mainly at the age of 45–60, and both men and women of all racial and ethnic populations are affected, but in men the disease occurs more often in more severe form. Of particular interest is the role of genetic factors, the innate and adaptive immune system, and neurovascular dysregulation underlying the spectrum of clinical signs of rosacea. Currently, the rosacea care algorithm is evolving in accordance with the phenotypic approach recommended by several regional and national authorities in clinical practice. However, the formal transition to this approach is still in its infancy, and significant support is required for its widespread adoption in everyday practice.rosacea, prevalence, populations, risk factors, genetic predisposition, medical care, phenotypic approach, reviewрозацеа, распространенность, популяции, факторы риска, генетическая предрасположенность, оказание медицинской помощи, фенотипический подход, обзор1.Nowicka D., Chilicka K., Dzieńdziora-Urbińska I., Szyguła R. Skin-care in Rosacea from the Cosmetologist's Perspective: A Narrative Review. J Clin Med. 2022;12(1). doi: 10.3390/jcm12010115.2.Kang C. N., Shah M., Tan J. Rosacea: An Update in Diagnosis, Classification and Management. Skin Therapy Lett. 2021;26(4):1-8.3.Buddenkotte J., Steinhoff M. Recent advances in understanding and managing rosacea. F1000Res. 2018;7. doi: 10.12688/f1000research.16537.14.Wang Y., Zhang H., Fang R., Tang K., Sun Q. The top 100 most cited articles in rosacea: a bibliometric analysis. J Eur Acad Dermatol Venereol. 2020;34(10):2177-2182. doi: 10.1111/jdv.16305.5.Miyachi Y., Yamasaki K., Fujita T., Fujii C. Metronidazole gel (0.75%) in Japanese patients with rosacea: A randomized, vehicle-controlled, phase 3 study. J Dermatol. 2022;49(3):330-340. doi: 10.1111/1346-8138.16254.6.Schaller M., Dirschka T., Lonne-Rahm S. B., Micali G., Stein Gold L. F., Tan J., Del Rosso J. The Importance of Assessing Burning and Stinging when Managing Rosacea: A Review. Acta Derm Venereol. 2021;101(10). doi: 10.2340/actadv.v101.356.7.van Zuuren E. J., Arents B. W.M., van der Linden M. M.D., Vermeulen S., Fedorowicz Z., Tan J. Rosacea: New Concepts in Classification and Treatment. Am J Clin Dermatol. 2021;22(4):457-465. doi: 10.1007/s40257-021-00595-7.8.Gether L., Overgaard L. K., Egeberg A., Thyssen J. P. Incidence and prevalence of rosacea: a systematic review and meta-analysis. Br J Dermatol. 2018;179(2):282-289. doi: 10.1111/bjd.16481.9.Hu X. M., Li Z. X., Zhang D. Y., Yang Y. C., Zheng S. Y., Zhang Q., Wan X. X., Li J., Yang R. H., Xiong K. Current research and clinical trends in rosacea pathogenesis. Heliyon. 2022;8(10). doi: 10.1016/j.heliyon.2022.e10874.10.Zierl S., Guertler A., Hildebrand J. A., Clanner-Engelshofen B. M., French L. E., Reinholz M. A comprehensive epidemiological study of rosacea in Germany. Eur J Dermatol. 2021:31(6):744-751. doi: 10.1684/ejd.2021.4165.11.Barakji Y. A., Rønnstad A. T.M., Christensen M. O., Zachariae C., Wienholtz N. K.F., Halling A. S., Maul J. T., Thomsen S. F., Egeberg A., Thyssen J. P. Assessment of Frequency of Rosacea Subtypes in Patients With Rosacea: A Systematic Review and Meta-analysis. JAMA Dermatol. 2022;158(6):617-625. doi: 10.1001/jamadematol.2022.0526.12.Alia E., Feng H. Rosacea pathogenesis, common triggers, and dietary role: The cause, the trigger, and the positive effects of different foods. Clin Dermatol.2022;40(2):122-127. doi: 10.1016/j.clindermatol.2021.10.004.13.Maliyar K., Abdulla S. J. Dermatology: how to manage rosacea in skin of colour. Drugs Context. 2022;(11):2021-11-1. doi: 10.7573/dic.2021-11-1.14.Sarkar R., Podder I., Jagadeesan S. Rosacea in skin of color: A comprehensive review. Indian J Dermatol Venereol Leprol. 2020;86(6):611-621. doi: 10.4103/ijdvl.IJDVL_769_19.15.Alexis A. F., Callender V. D., Baldwin H. E., Desai S. R., Rendon M. I., Taylor S. C. Global epidemiology and clinical spectrum of rosacea, highlighting skin of color: Review and clinical practice experience. J Am Acad Dermatol. 2019;80(6):1722-1729. doi: 10.1016/j.jaad.2018.08.049.16.Nobeyama Y., Aihara Y., Asahina A. Characteristics of Rosacea and Similar Diseases in Patients Wearing Face Masks. Skin Appendage Disord. 2022;8(6):462-468. doi: 10.1159/000525024.17.Searle T., Ali F. R., Carolides S., Al-Niaimi F. Rosacea and Diet: What is New in 2021? J Clin Aesthet Dermatol. 2021;14(12):49-54.18.Wang B., Yan B., Zhao Z., Tang Y., Huang Y. X., Jian D., Shi W., Xie H., Wang Y., Li J. Relationship Between Tea Drinking Behaviour and Rosacea: A Clinical Case-control Study. Acta Derm Venereol. 2021;101(6). doi: 10.2340/00015555-3849.19.Wang B., Huang X., Zhao Z., Tang Y., Xie H., Deng Z., Li J. Interaction between body weight status and spicy food consumption on the risk of rosacea: A multi-central, hospital-based, case-control study. J Cosmet Dermatol. 2022;21(7):3068-3077. doi: 10.1111/jocd.14556.20.Dall'Oglio F., Fusto C., Micali G. Intrafamilial Transmission of Rosacea Spanning Six Generations: A Retrospective Observational Study. J Clin Aesthet Dermatol. 2022;15(2):35-39.21.Chang A. L.S., Raber I., Xu J., Li R., Spitale R., Chen J., Kiefer A. K., Tian C., Eriksson N. K., Hinds D. A., Tung J. Y. Assessment of the genetic basis of rosacea by genome-wide association study. J Invest Dermatol. 2015;135(6):1548-1555. doi: 10.1038/jid.2015.53.22.Awosika O., Oussedik E. Genetic Predisposition to Rosacea. Dermatol Clin. 2018;36(2):87-92. doi: 10.1016/j.det.2017.11.002.23.Aponte J. L., Chiano M. N., Yerges-Armstrong L. M., Hinds D. A., Tian C., Gupta A., Guo C., Fraser D. J., Freudenberg J. M., Rajpal D. K., Ehm M. G., Waterworth D. M. Assessment of rosacea symptom severity by genome-wide association study and expression analysis highlights immuno-inflammatory and skin pigmentation genes. Hum Mol Genet. 2018;27(15):2762-2772. doi: 10.1093/hmg/ddy184.24.Gallo R. L., Granstein R. D., Kang S. et al. Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2018;78(1):148-155. doi: 10.1016/j.jaad.2017.08.037.25.Schaller M., Almeida L. M.C., Bewley A., Cribier B., Del Rosso J., Dlova N. C., Gallo R. L. et al. Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel. Br J Dermatol. 2020;182(5):269-1276. doi: 10.1111/bjd.18420.26.Zierl S., Hildebrand J. A., Guertler A., Dietrich C., Clanner-Engelshofen B. M., French L. E., Reinholz M. Clinical clues to identify patients with ocular rosacea — a Germany-wide epidemiologic analysis. Int J Dermatol. 2022;61(7):880-885. doi: 10.1111/ijd.16235.27.Woo Y. R., Cho M., Ju H. J., Bae J. M., Cho S. H., Lee J. D., Kim H. S. Ocular Comorbidities in Rosacea: A Case-Control Study Based on Seven Institutions. J Clin Med. 2021;10(13). doi: 10.3390/jcm10132897.28.Sarac G., Cankaya C., Ozcan K. N., Cenk H., Kapicioglu Y. K. Increased frequency of Demodex blepharitis in rosacea and facial demodicosis patients. J Cosmet Dermatol. 2020;19(5):1260-1265. doi: 10.1111/jocd.13150.29.Ogrum A., Alim S. In which rosacea patients should Demodex in the eyelashes be investigated? Niger J Clin Pract. 2020;23(8):1039-1043. doi: 10.4103/njcp.njcp_590_18.30.Wu A. K., Liu F. F., Xie H. F., Zhao Z. X., Tang Y., Huang Y. X., Jian D., Shi W., Wang B., Li J. Clinical Features and Risk Factors for Nasal Rosacea: A Hospital-Based Retrospective Study. Dermatol Ther (Heidelb). 2021;11(6):1953-1963. doi: 10.1007/s13555-021-00605-w.31.Tan J., Berg M., Gallo R. L., Del Rosso J. Q. Applying the phenotype approach for rosacea to practice and research. Br J Dermatol. 2018;179(3):741-746. doi: 10.1111/bjd.16815.